Professional Relations and Public Policy Position Papers and Responses
2006 and Earlier
Comments to the SACGHS
(November 2006)
Comments to the SACGHS regarding Gene Patents
(June 2006)
Comments
to the SACGHS regarding proposed Large Population
Study (June 2006)
Comments to CMS regarding
Medically Unbelievable Edits
(May
2006)
Comments to FDA
regarding CFTR Guidance Document
(May 2006)
Comments to CME
regarding Equivalent Quality Control
(May 2006)
LabCorp v. Metabolite brief
(Dec 2005)
Comments to FDA regarding drug safety information
(Dec. 2005)
Comments to NHIC regarding the Oncotype DX
Test (Aug. 2005)
Letter to Trailblazer regarding cytogenetics
reimbursement
(Aug.
2005)
AMP Response to SACGHS Draft
Report link to document AMPComments.
(May 2005)
Letter to Secretary Leavitt
Regarding Cytology Proficiency Testing
(May 2005)
AMP Letter of Support for S.306, the
Genetic Nondiscrimination Act
(Feb. 2005)
AMP Comments Regarding the NIH
Proposed “Best Practices for the Licensing of Genomic Inventions.”
(Jan.
2005)
AMP Response to the DHHS Secretary's
Advisory Committee on Genetic Testing (Jan.
2000)
AMP Position on Patenting of Genetic
Tests
(Nov. 1999)11/14/2007